Peptonic Medical files patent application for its vaginal gel
Stockholm May 30th, 2017. Peptonic Medical AB (publ) (‘Peptonic’ or the ‘Company’) today announced that the Company has filed a patent application concerning the use of its vaginal gel for the treatment of symptoms associated with vaginal atrophy. The application was filed with The Swedish Patent and Registration Office. During the coming twelve months, the Company needs to decide in which additional countries the application will be filed. - We have been working diligently with our patent attorneys to develop a patent application for the gel without oxytocin. Now we feel that